Skip to content

Edwards 23F Guide Sheath 9880GSRecalls & reported problems

Edwards Lifesciences LLC · Edwards 23F Guide Sheath · Class 3

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00690103219784), received between Apr 22, 2026 and Apr 22, 2026 — classified as 1 malfunction.

The most frequently reported specific device problem is “Air/Gas in Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 1 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Air/Gas in Device1

Patient problems

  • Air Embolism1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 22, 2026Air/Gas in Device

    EDWARDS RECEIVED A REPORT OF A SAPIEN M3 PROCEDURE IN THE MITRAL POSITION IN WHICH AN ANEURYSMAL SEPTUM REQUIRED LATERAL ADVANCEMENT OF THE GUIDE SHEATH (GS) TO GAIN LEFT ATRIAL (LA) ACCESS. THE GS APPEARED CLEAR OF TISSUE ON 3D TEE; HOWEVER, EMBOLIZATION OF AIR WAS OBSERVED DUE TO THE GS PULLING AGAINST THE LATERAL WALL DURING GS ASPIRATION AND FLUSHING. THE AIR WAS NOTED AFTER INTRODUCTION OF THE GS INTO THE LEFT ATRIUM AND DURING SUBSEQUENT GUIDE SHEATH AND DOCK STEERABLE CATHETER (DSC) MANIPULATION, APPROXIMATELY MID-PROCEDURE. ADDITIONAL INFORMATION WAS SUBSEQUENTLY RECEIVED FROM THE FIELD, DURING INITIAL GS INSERTION, ASPIRATION RESULTED IN AIR AND SOME BLOOD WHILE THE WIRE AND INTRODUCER WERE POSITIONED ACROSS THE GS SEALS. THE FIRST GS WAS REMOVED AND RE-PREPPED. THE INTERATRIAL SEPTUM WAS BALLOONED, AND THE GS WAS REINSERTED ACROSS THE SEPTUM. WHEN THE REINSERTED GS WAS FLUSHED AND ASPIRATED DURING WIRE AND INTRODUCER REMOVAL, ONLY AIR WAS OBTAINED. THE GS WAS THEN REMOVED AND EXCHANGED FOR A SECOND GS THAT WAS POSITIONED LATERALLY. DURING ASPIRATION OF THE SECOND GS ASSOCIATED WITH WIRE AND INTRODUCER REMOVAL, BLOOD WAS OBTAINED; HOWEVER, SOME AIR INGRESS WAS OBSERVED, AN

    Patient problems: Air Embolism

    MAUDE report 24955105 ↗

Other Prosthesis, Mitral Valve, Percutaneously Delivered devices

All Prosthesis, Mitral Valve, Percutaneously Delivered devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page